Vortex Imaging Raises $12 Million to Advance Computational Ultrasound System
California-based Vortex Imaging has announced the closing of a $12 million financing round supported by existing and new investors, including 10D Ventures, Entrée Capital, Harel T.E.C Partnership, Connecticut Innovations, and PhiFund Ventures. The funding will support the continued development, regulatory clearance, and market launch of the company’s computational ultrasound system.
Vortex Imaging is developing a compact ultrasound-based imaging system that uses computational image reconstruction technology with GPUs-on-Cloud to enable high-quality 3D volumetric imaging at the point of care. Many advanced imaging workflows currently rely on centralized radiology suites, which can result in delays in accessing imaging and patient care. Vortex Imaging’s system aims to reduce variability associated with conventional ultrasound workflows by enabling standardized, reproducible volumetric datasets with a reduced learning curve, while avoiding ionizing radiation and the need for large imaging infrastructure. The reconstructed images are intended to provide physicians with advanced 3D volumetric visualization in a format traditionally associated with CT and MRI, while maintaining the accessibility and portability of ultrasound.
Tomer Ben David, CEO of Vortex Imaging, stated that the company is focused on transforming ultrasound from a highly operator-dependent modality into a standardized, volumetric imaging system capable of delivering advanced 3D clinical insights directly at the point of care, and that the company is excited to have the support of experienced investors and board members as it advances toward FDA clearance and initial clinical deployment.
Vortex Imaging also announced the appointment of Ori Hadomi, former CEO of Mazor Robotics and current Vice President of Strategic Initiatives and Partnerships at Medtronic, as Chairman of the Board. The expanded board includes Chris Cleary, former Vice President of Corporate Development at Medtronic and former GE Healthcare executive; Yahal Zilka, co-founder and Managing Partner at 10D Ventures; and Dr. Yael Grunbaum, Partner at Entrée Capital and Head of Entrée Bio. Vortex Imaging’s initial clinical focus is on urology and nephrology, with broader future applications planned across additional diagnostic and procedural domains. Ori Hadomi said the combination of high-quality volumetric imaging, reduced operator dependency, and a compact ultrasound-based platform could enable a more scalable and standardized approach to imaging across healthcare systems.
